INSIGHTS ON PARTNERING

  • Consolidating IRT And Clinical Supply Management To Save Time And Costs
    Consolidating IRT And Clinical Supply Management To Save Time And Costs

    It is difficult to quantify the soft costs of managing a clinical trial. One factor guilty of contributing to spiraling soft costs is time. Download Almac’s case study that demonstrates how Almac’s One Clinical Trial Supply Solution helped a pharmaceutical company streamline its clinical trial operations, resulting in time and cost savings.

  • The Increased Need For Expertise And Flexibility In Packaging

    As companies are looking to reduce their supplier base and shifting towards more strategic relationships with key suppliers to achieve economies of scale, learn how contract suppliers can benefit from developing strategic partnerships with other vendors and operating as one entity.

  • Incorporating The Patient Voice To Improve Ulcerative Colitis Recruitment

    Dr. Joan Meyer, Covance Executive Director of Strategy & Planning for Inflammation, Infectious Diseases and General Medicine, discusses her team’s efforts to better understand patients’ opinions about inflammatory bowel disease trials and develop patient-centered clinical strategies to improve study recruitment.

  • Advancing A Diabetes Multi-Registration Program

    A large pharmaceutical company asked Covance to support their studies for a diabetes Phase III program specifically to register a drug to treat Type 2 Diabetes. Read how Covance utilized its rich central laboratory services database and helped the sponsor achieve first patient in (FPI) ahead of schedule for all studies in the program and beat historical industry performance across a number of key metrics.

  • Optimizing Protocol Design And Enhancing Patient Enrollment

    An emerging biopharmaceutical company was designing a Phase II trial in patients who had Type 2 Diabetes, Stage 3 chronic kidney disease (CKD) and macroalbuminuria. They were uncertain about how to balance the selection of the right patients for their trial endpoints with the ability to achieve rapid subject recruitment. Read how LabCorp de-identified clinical laboratory data helped evaluate the protocol feasibility and the overall design of the study while also making an adjustment in eligibility criteria was forecast to double the eligible patient pool – without impacting study endpoints.

  • Closed Loop Technology And Integrated Expertise Mitigates Risk

    Discover how Almac helped one pharmaceutical company streamline processes and remove risk from their multiple clinical trial applications while maintaining data integrity with One Unified Clinical Trial Supply Solution.

More Insights On Partnering

PARTNERING MULTIMEDIA

More Partnering Multimedia

PARTNERING SOLUTIONS

  • Almac ONE: One Unified Clinical Trial Supply Solution

    Almac’s One Unified Clinical Trial Supply Solution has one objective to guarantee the study drug is with the patient at the right time while ensuring the complete chain of custody and minimising wastage of drug from production to destruction.

  • Real-Time Data. Real-World Impact.
    Real-Time Data. Real-World Impact.

    Up to 60% of clinical development time and 40% of cost are spent on patient recruitment. Data can help, but simply accessing more data only muddies your decision making. With Covance, you get the right analysis on the right data to empower your studies. Recruit eligible patients that fit your protocol faster, identify and secure proven and/or new sites, forecast and measure progress more efficiently. With Covance’s proprietary data, your program hits its mark.

  • ConneX
    ConneX

    ConneX is a global travel solution providing in-market services and support, designed to meet the unique travel needs of each study, whether it be for rare disease, diverse populations, pediatrics, etc. Our offering removes the burden of complex travel arrangement from site staff, while peace of mind is established for participants, their families and caregivers.

More Partnering Solutions